南方医科大学学报 ›› 2020, Vol. 40 ›› Issue (10): 1390-1398.doi: 10.12122/j.issn.1673-4254.2020.10.03

• • 上一篇    下一篇

miR-133b靶向YES1抑制心肌缺血再灌注引起的心肌细胞凋亡和活性氧簇的积累

彭 兴,林 玲,周祥群,杨大英,曹 阳,尹涛源,刘媛媛   

  • 出版日期:2020-10-20 发布日期:2020-10-20

miR-133b inhibits myocardial ischemia-reperfusion-induced cardiomyocyte apoptosis and accumulation of reactive oxygen species in rats by targeting YES1

  • Online:2020-10-20 Published:2020-10-20

摘要: 目的 探究miR-133b对心肌缺血再灌注(I/R)诱导心肌细胞凋亡的作用及机制。方法 体内实验,将大鼠随机分为4组:假手术组、模型组、转染腺病毒对照组、转染miR-133b腺病毒组,每组9只。在左心室心肌的6个随机点注射转染复合物后,利用左侧冠状动脉前降支打活结方法诱导心肌I/R。通过RT-qPCR检测miR-133b的表达水平,FDP-1 HRVBRS分析系统测定心功能,酶联免疫吸附法测定血清肌酸激酶同工酶(CK-MB)和心肌肌钙蛋白(I CTnI)水平,HE染色观察心肌损伤,流式细胞术检测细胞凋亡,2,7-二氯荧光素双乙酸酯(DCFH-DA)探针测定ROS含量。体外实验,心肌H9C2细胞经缺氧/复氧(H/R)处理后,转染miR-NCmiR-133b mimicRT-qPCR检测miR-133b的表达水平,流式细胞术检测细胞凋亡,DCFH-DA探针测定ROS含量;双荧光素酶报告实验验证靶向关系;转染pc-YES1miR-133b mimic后,Western blot检测YES1的表达水平,流式细胞术检测细胞凋亡,DCFH-DA探针测定ROS含量。结果 I/R组相比,AdmiR-133b组大鼠心肌中miR-133b的表达显著上调,LVEDPcTnICK-MB水平显著降低,LVSP+dp/dt-dp/dtHRCF水平显著升高,病理损伤显著减轻,心肌细胞凋亡和ROS积累显著减少(P<0.01)。与H/R组相比,miR-133b mimicH9C2细胞的miR-133b表达显著上调,细胞凋亡和ROS积累显著减少(P<0.01)。miR-133bYES13UTR区存在靶向结合位点,共转染YES1 WTmiR-133b mimic可以显著降低荧光素酶活性(P<0.01)。miR-133b mimic 组与H/R组相比H9C2细胞中YES1蛋白的表达显著下调(P<0.01)。共转染pc-YES1逆转miR-133b过表达对心肌细胞凋亡和ROS积累的作用。结论 无论是在体内还是体外,miR-133b靶向YES1抑制I/R引起的心肌细胞凋亡和ROS的积累,从而减轻心肌I/R损伤。

关键词: 心肌缺血再灌注, miR-133b, YES1, 细胞凋亡, 活性氧

Abstract: Objective To investigate the effect of miR-133b on cardiomyocyte apoptosis induced by myocardial ischemia-reperfusion (I/R) and explore the mechanism. Methods Thirty-six adult SD rats were randomized into sham-operated group, I/R group, AdmiR-NC group and AdmiR-133b group, and rat models of myocardial I/R were established in the latter 3 groups with myocardial injections of saline or recombinant adenoviruses in the left ventricle. The expression of MiR-133b was detected using RT-qPCR, and cardiac function of the rats was determined using FDP 1 HRV and BRS analysis system. Serum CK-MB and cTnI levels were determined by ELISA, myocardial injury was evaluated with HE staining, cardiomocyte apoptosis was detected by flow cytometry, and ROS content was determined using a DCFH-DA probe. In the in vitro experiment, H9C2 myocardial cells with hypoxia/reoxygenation (H/R) treatment were transfected with Mir-NC or MiR-133b mimic, and the cellular expression of MiR-133b, cell apoptosis, and ROS content were determined. Dual luciferase reporter assay was performed to verify the targeting relationship between miR-133b and YES1. The effects of pc-YES1 or miR-133b mimic transfection on YES1 expression, apoptosis, and ROS content in H9C2 cells were evaluated. Results Compared with those in I/R group, miR-133b expression was obviously up-regulated, LVEDP, cTnI and CK-MB levels were
significantly decreased, and LVSP, +dp/dt, -dp/dt, HR and CF levels were increased in admiR-133b group (
P<0.01). The rats in
admiR-133b group showed obviously reduced pathological damage, cell apoptosis and ROS content compared with those in I/R group (
P<0.01). In H9C2 cells exposed to H/R, transfection with miR-133b mimic significantly up-regulated miR-133b expression and decreased cell apoptosis and ROS content (P<0.01). The results of dual luciferase reporter assay suggested a direct targeting relationship between miR-133b and YES1, and MiR-133b mimic transfection significantly down-regulated YES1 protein expression in cells with H/R exposure (P<0.01). Co-transfection with pc-YES1 reversed the effect of miR-133b overexpression on myocardial cell apoptosis and ROS accumulation. Conclusion miR-133b can inhibit I/R-induced myocardial cell apoptosis and ROS accumulation by targeting YES1 to reduce myocardial I/R injury in rats.

Key words: myocardial ischemia-reperfusion, miR-133b, YES1, apoptosis, reactive oxygen species